Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
SmithKline Beecham Holdings Corporation main competitors are Novartis, Boehringer Ingelheim, and Allergan plc.
Competitor Summary. See how SmithKline Beecham Holdings Corporation compares to its main competitors:
| Company | Founding date | Zippia score | Headquarters | # of Locations | Revenue | Employees |
|---|---|---|---|---|---|---|
| 1996 | 4.3 | Wilmington, DE | 1 | - | 1,500 | |
| 1948 | 4.8 | Irvine, CA | 1 | $7.2B | 11,400 | |
| 1981 | 4.8 | Duluth, GA | 1 | $2.7B | 6,900 | |
| 2012 | 4.5 | - | - | $53.0M | 635 | |
| 1860 | 4.7 | Madison, NJ | 1 | $22.4B | 49,732 | |
| 1996 | 4.9 | East Hanover, NJ | 16 | $51.7B | 110,000 | |
| 1987 | 4.7 | South San Francisco, CA | 1 | $61.0B | 94,442 | |
| 1984 | 4.6 | Ridgefield, CT | 5 | $17.2B | 52,391 | |
| 1954 | 4.8 | New York, NY | 1 | $3.6B | 6,200 | |
| 1987 | 4.6 | Houston, TX | 3 | $291.6M | 660 | |
| 2004 | 4.9 | Wayne, PA | 1 | $15.2B | 3,500 | |
| 1953 | 4.9 | Raritan, NJ | 4 | $601.4M | 1,500 | |
| 1984 | 4.9 | Parsippany-Troy Hills, NJ | 1 | $5.9B | 21,600 | |
| 1987 | 4.6 | Miami, FL | 2 | $520.0M | 586 |
Rate how well SmithKline Beecham Holdings Corporation differentiates itself from its competitors.
| Company | Highest salary | Hourly salary |
|---|---|---|
SmithKline Beecham Holdings Corporation | $71,808 | $34.52 |
Novartis | $109,260 | $52.53 |
Boehringer Ingelheim | $104,335 | $50.16 |
Janssen | $103,283 | $49.66 |
Forest Laboratories | $99,820 | $47.99 |
Allergan plc | $99,134 | $47.66 |
Merial Limited | $93,288 | $44.85 |
Watson Pharma Pvt Ltd | $88,407 | $42.50 |
Wyeth Biopharma | $88,340 | $42.47 |
Cyberonics | $84,191 | $40.48 |
Roche Diagnostics Middle East | $80,917 | $38.90 |
Roche Holding AG | $77,432 | $37.23 |
Shire Pharmaceuticals Inc | $76,592 | $36.82 |
Noven | $72,456 | $34.83 |
Do you work at SmithKline Beecham Holdings Corporation?
Does SmithKline Beecham Holdings Corporation effectively differentiate itself from competitors?
| Job title | Male | Female |
|---|---|---|
| Janssen | 51% | 49% |
| Novartis | 54% | 46% |
| Allergan plc | 55% | 45% |
| Roche Holding AG | 56% | 44% |
| SmithKline Beecham Holdings Corporation | - | - |
| Company | White | Hispanic or Latino | Black or African American | Asian | Unknown | Diversity score |
|---|---|---|---|---|---|---|
| 55% | 15% | 10% | 15% | 4% | 9.9 | |
| 57% | 17% | 10% | 12% | 4% | 9.8 | |
| 52% | 19% | 10% | 15% | 5% | 9.9 | |
| 57% | 19% | 9% | 11% | 3% | 9.7 |